CD47 and leiomyosarcoma: Edris et al. demonstrated in their study that CD47 is expressed at higher levels in leiomyosarcoma tumor cells compared to leiomyoma cells and that in vitro anti-CD47 monoclonal antibodies enhance macrophage-mediated phagocytosis in leiomyosarcoma cells [22].